Literature DB >> 22354030

Ceramide and Toll-like receptor 4 are mobilized into membrane rafts in response to Helicobacter pylori infection in gastric epithelial cells.

Dah-Yuu Lu1, Hui-Chen Chen, Mei-Shiang Yang, Yuan-Man Hsu, Hwai-Jeng Lin, Chih-Hsin Tang, Che-Hsin Lee, Cheng-Kuo Lai, Chun-Jung Lin, Woei-Cherng Shyu, Fong-Yan Lin, Chih-Ho Lai.   

Abstract

Helicobacter pylori infection is thought to be involved in the development of several gastric diseases. Two H. pylori virulence factors (vacuolating cytotoxin A and cytotoxin-associated gene A) reportedly interact with lipid rafts in gastric epithelial cells. The role of Toll-like receptor (TLR)-mediated signaling in response to H. pylori infection has been investigated extensively in host cells. However, the receptor molecules in lipid rafts that are involved in H. pylori-induced innate sensing have not been well characterized. This study investigated whether lipid rafts play a role in H. pylori-induced ceramide secretion and TLR4 expression and thereby contribute to inflammation in gastric epithelial cells. We observed that both TLR4 and MD-2 mRNA and protein levels were significantly higher in H. pylori-infected AGS cells than in mock-infected cells. Moreover, significantly more TLR4 protein was detected in detergent-resistant membranes extracted from H. pylori-infected AGS cells than in those extracted from mock-infected cells. However, this effect was attenuated by the treatment of cells with cholesterol-usurping agents, suggesting that H. pylori-induced TLR4 signaling is dependent on cholesterol-rich microdomains. Similarly, the level of cellular ceramide was elevated and ceramide was translocated into lipid rafts after H. pylori infection, leading to interleukin-8 (IL-8) production. Using the sphingomyelinase inhibitor imipramine, we observed that H. pylori-induced TLR4 expression was ceramide dependent. These results indicate the mobilization of ceramide and TLR4 into lipid rafts by H. pylori infection in response to inflammation in gastric epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354030      PMCID: PMC3347442          DOI: 10.1128/IAI.05856-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

Review 1.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors:  G Zhang; S Ghosh
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  Binding and internalization of Helicobacter pylori VacA via cellular lipid rafts in epithelial cells.

Authors:  Chun-Hsien Kuo; Wen-Ching Wang
Journal:  Biochem Biophys Res Commun       Date:  2003-04-04       Impact factor: 3.575

4.  Identification of glycolipid receptors for Helicobacter pylori by TLC-immunostaining.

Authors:  T Saitoh; H Natomi; W L Zhao; K Okuzumi; K Sugano; M Iwamori; Y Nagai
Journal:  FEBS Lett       Date:  1991-05-06       Impact factor: 4.124

5.  A guided tour into subcellular colocalization analysis in light microscopy.

Authors:  S Bolte; F P Cordelières
Journal:  J Microsc       Date:  2006-12       Impact factor: 1.758

Review 6.  Endotoxin recognition and signal transduction by the TLR4/MD2-complex.

Authors:  Katherine A Fitzgerald; Daniel C Rowe; Douglas T Golenbock
Journal:  Microbes Infect       Date:  2004-12       Impact factor: 2.700

Review 7.  Helicobacter pylori VacA, a paradigm for toxin multifunctionality.

Authors:  Timothy L Cover; Steven R Blanke
Journal:  Nat Rev Microbiol       Date:  2005-04       Impact factor: 60.633

8.  Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis.

Authors:  Shunji Ishihara; Mohammad Azharul Karim Rumi; Yasunori Kadowaki; Cesar Francisco Ortega-Cava; Takafumi Yuki; Nagisa Yoshino; Youichi Miyaoka; Hideaki Kazumori; Norihisa Ishimura; Yuji Amano; Yoshikazu Kinoshita
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

9.  Glycosylphosphatidylinositol-anchored proteins and actin cytoskeleton modulate chloride transport by channels formed by the Helicobacter pylori vacuolating cytotoxin VacA in HeLa cells.

Authors:  Nils C Gauthier; Vittorio Ricci; Pierre Gounon; Anne Doye; Michel Tauc; Philippe Poujeol; Patrice Boquet
Journal:  J Biol Chem       Date:  2003-12-14       Impact factor: 5.157

10.  Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells.

Authors:  Michael F Smith; Anastasia Mitchell; Guolian Li; Song Ding; Ann Marie Fitzmaurice; Kieran Ryan; Sheila Crowe; Joanna B Goldberg
Journal:  J Biol Chem       Date:  2003-06-13       Impact factor: 5.157

View more
  22 in total

1.  Decreased PLUNC expression in nasal polyps is associated with multibacterial colonization in chronic rhinosinusitis patients.

Authors:  Yung-An Tsou; Ming-Te Peng; Yi-Fang Wu; Chih-Ho Lai; Chia-Der Lin; Chih-Jaan Tai; Ming-Hsui Tsai; Chuan-Mu Chen; Hui-Chen Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-05       Impact factor: 2.503

Review 2.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

Authors:  Erhard Bieberich
Journal:  Chem Phys Lipids       Date:  2018-09-05       Impact factor: 3.329

Review 3.  Role of Liver X Receptor in Mastitis Therapy and Regulation of Milk Fat Synthesis.

Authors:  Xiaoyu Hu; Naisheng Zhang; Yunhe Fu
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-07-31       Impact factor: 2.673

4.  P2X7 receptor activation increases expression of caveolin-1 and formation of macrophage lipid rafts, thereby boosting CD39 activity.

Authors:  Luiz Eduardo Baggio Savio; Paola de Andrade Mello; Stephanie Alexia Cristina Silva Santos; Júlia Costa de Sousa; Suellen D S Oliveira; Richard D Minshall; Eleonora Kurtenbach; Yan Wu; Maria Serena Longhi; Simon C Robson; Robson Coutinho-Silva
Journal:  J Cell Sci       Date:  2020-03-06       Impact factor: 5.285

5.  TLR4 and TLR2 expression in biopsy specimens from antral and corporal stomach zones in Helicobacter pylori infections.

Authors:  Mohammad Reza Khakzad; Ahmad Saffari; Niloofar Mohamadpour; Mojtaba Sankian; Abdolreza Varasteh; Farhad Salari; Mojtaba Meshkat
Journal:  Rep Biochem Mol Biol       Date:  2014-10

6.  Gut Commensal Parabacteroides goldsteinii MTS01 Alters Gut Microbiota Composition and Reduces Cholesterol to Mitigate Helicobacter pylori-Induced Pathogenesis.

Authors:  Chih-Ho Lai; Tzu-Lung Lin; Mei-Zi Huang; Shiao-Wen Li; Hui-Yu Wu; Ya-Fang Chiu; Chia-Yu Yang; Cheng-Hsun Chiu; Hsin-Chih Lai
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 7.  Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis.

Authors:  Barbara Kronsteiner; Josep Bassaganya-Riera; Casandra Philipson; Monica Viladomiu; Adria Carbo; Vida Abedi; Raquel Hontecillas
Journal:  Gut Microbes       Date:  2016

8.  Anti-inflammatory action of lipid nanocarrier-delivered myriocin: therapeutic potential in cystic fibrosis.

Authors:  Anna Caretti; Alessandra Bragonzi; Marcella Facchini; Ida De Fino; Camilla Riva; Paolo Gasco; Claudia Musicanti; Josefina Casas; Gemma Fabriàs; Riccardo Ghidoni; Paola Signorelli
Journal:  Biochim Biophys Acta       Date:  2013-10-18

9.  Inhibition of Helicobacter pylori CagA-Induced Pathogenesis by Methylantcinate B from Antrodia camphorata.

Authors:  Chun-Jung Lin; Yerra Koteswara Rao; Chiu-Lien Hung; Chun-Lung Feng; Hsien-Yuan Lane; David T W Tzeng; Ping-Ning Hsu; Chih-Ho Lai; Yew-Min Tzeng
Journal:  Evid Based Complement Alternat Med       Date:  2013-01-08       Impact factor: 2.629

10.  Impact of cholesterol on disease progression.

Authors:  Chun-Jung Lin; Cheng-Kuo Lai; Min-Chuan Kao; Lii-Tzu Wu; U-Ging Lo; Li-Chiung Lin; Yu-An Chen; Ho Lin; Jer-Tsong Hsieh; Chih-Ho Lai; Chia-Der Lin
Journal:  Biomedicine (Taipei)       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.